NAUTILUS BIOTECHNOLOGY INC's ticker is NAUT and the CUSIP is 63909J108. A total of 76 filers reported holding NAUTILUS BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,963,078 | -18.2% | 937,683 | +0.2% | 0.00% | – |
Q2 2023 | $3,622,935 | +83.1% | 936,159 | +31.0% | 0.00% | – |
Q1 2023 | $1,979,176 | -21.7% | 714,504 | -49.1% | 0.00% | – |
Q4 2022 | $2,527,934 | +82.8% | 1,404,408 | +115.3% | 0.00% | – |
Q3 2022 | $1,383,000 | -11.4% | 652,325 | +12.4% | 0.00% | – |
Q2 2022 | $1,561,000 | +93.4% | 580,183 | +212.0% | 0.00% | – |
Q1 2022 | $807,000 | -12.1% | 185,955 | +4.9% | 0.00% | – |
Q4 2021 | $918,000 | -5.2% | 177,200 | +12.4% | 0.00% | – |
Q3 2021 | $968,000 | – | 157,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Madrona Venture Group, LLC | 6,020,770 | $47,848,000 | 7.75% |
AMAZON COM INC | 1,457,055 | $14,716,000 | 3.85% |
Ally Bridge Group (NY) LLC | 1,500,000 | $15,150,000 | 3.76% |
Affinity Asset Advisors, LLC | 900,000 | $9,090,000 | 3.25% |
Bain Capital Life Sciences Investors, LLC | 2,000,000 | $20,200,000 | 1.32% |
Perceptive Advisors | 17,822,302 | $180,004,000 | 1.17% |
SPHERA FUNDS MANAGEMENT LTD. | 800,000 | $8,080,000 | 0.55% |
HILLMAN CO | 200,000 | $2,020,000 | 0.52% |
RA Capital Management | 2,471,430 | $24,961,000 | 0.40% |
Nantahala Capital Management | 1,190,810 | $12,027,000 | 0.34% |